Madbouly Egypt's development model at UN conference    Egypt's Foreign Minister urges diplomacy on Iran nuclear issue in IAEA call    Egypt, Iran FMs discuss Gaza truce, nuclear talks revival    Egypt's Environment Minister calls for stronger action on desertification, climate resilience in Africa    Egypt's Q3 GDP growth hits three-year high of 4.77%    Peace is not imposed by bombing… nor achieved by normalisation peoples reject: Al-Sisi    Al-Sisi reaffirms Egypt's support for Libyan unity, withdrawal of foreign forces    Spinneys Opens A New Store in Hurghada    Egypt to launch new dialysis filter factory in July, covering 65% of domestic demand    Egypt reveals heritage e-training portal    Egypt leverages diplomacy to advance global health partnerships    Egypt to toughen truck safety rules following fatal Ring Road accident    Egypt condemns Pakistan convoy attack, voices solidarity    Egypt, Mauritania eye joint healthcare plans    Egypt's FM, UK security adviser discuss de-escalation    US Fed holds rates steady    EGX ends in green on June 16    Egypt's EHA, Schneider Electric sign MoU on sustainable infrastructure    Sisi launches new support initiative for families of war, terrorism victims    Grand Egyptian Museum opening delayed to Q4    Egypt delays Grand Museum opening to Q4 amid regional tensions    Egypt expands e-ticketing to 110 heritage sites, adds self-service kiosks at Saqqara    Egypt's EDA joins high-level Africa-Europe medicines regulatory talks    Egypt's Irrigation Minister urges scientific cooperation to tackle water scarcity    Egypt discovers three New Kingdom tombs in Luxor's Dra' Abu El-Naga    Egypt launches "Memory of the City" app to document urban history    Palm Hills Squash Open debuts with 48 international stars, $250,000 prize pool    Egypt's Democratic Generation Party Evaluates 84 Candidates Ahead of Parliamentary Vote    On Sport to broadcast Pan Arab Golf Championship for Juniors and Ladies in Egypt    Golf Festival in Cairo to mark Arab Golf Federation's 50th anniversary    Germany among EU's priciest labour markets – official data    Cabinet approves establishment of national medical tourism council to boost healthcare sector    Egypt's PM follows up on Julius Nyerere dam project in Tanzania    Egypt's FM inspects Julius Nyerere Dam project in Tanzania    Paris Olympic gold '24 medals hit record value    A minute of silence for Egyptian sports    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Mayo Clinic researchers pinpoint genetic variations that might sway course of COVID-19
Published in Amwal Al Ghad on 11 - 08 - 2022

Researchers at U.S. non-profit organisation Mayo Clinic announced on Thursday that they discovered key human genomic signatures that could help explain why COVID-19 is severe in some people and mild in others.
After analysing volumes of diverse worldwide DNA sequence data, the scientists identified mutations in two human proteins that might sway the course of SARS-CoV-2, the virus responsible for COVID-19.
Their study reveals that variants in the genes for ACE2 and TMPRESS2 can lead to an increase or decrease in protein expression. An increase in protein expression might result in elevated COVID-19 susceptibility and severity, while a decrease might have a protective effect against the virus. Proteins play many critical roles in the body. In this case, ACE2 and TMPRESS2 provide critical entry points for SARS-CoV-2 to invade and infect human cells.
The study findings, published in Human Molecular Genetics, is suggesting a potential new diagnostic approach that is based on variation in the host cells rather than the constantly evolving virus itself.
"COVID-19 is a master of frequency in changing the sequences of its genes, but that only tells half of the story." said Lingxin Zhang, the lead author of the study and a researcher in the Pharmacogenomics Programme of the Centre for Individualised Medicine.
"Our findings suggest that the virus's interaction with proteins encoded by the human genome may also be a contributor to a person's disease outcome," Zhang added.
"These results can now be applied to DNA sequence data for patients infected with SARS-CoV-2 to potentially determine the degree of susceptibility to the disease,"
"I hope this methodology can be expanded for other genes involved in COVID-19, and that scientists and clinicians across the world can use this information to help their patients."
For the study, Zhang and her team delved deep into the DNA sequencing data of nearly 71,000 people worldwide, including nearly 30,000 racial and ethnic minorities, to identify sequence variants in the ACE2 and TMPRESS2 genes.
The team then analysed hundreds of protein variants encoded by those genes and identified variant genes that generated high and low expression levels. To do that, Zhang engineered cells capable of expressing the protein variants, and then, using color-coding, she and her team analysed the variants to see which were more or less stable.
The study used nearly a million generated cells and produced billions of data points, which the team analyzed using a series of technologies, including cell sorting, modern genomics, high throughput DNA sequencing and a computer algorithm.
"To our knowledge, it's the first time anyone has applied this approach to COVID-19," said Richard Weinshilboum, M.D., co-author of the study and a pharmacologist in the Centre for Individualised Medicine, and Department of Molecular Pharmacology and Experimental Therapeutics.
"This work would not have been possible without the dramatic advances that have occurred in DNA sequencing, joined together with parallel advances in our ability to test the functional and medical implications of individual variations in DNA sequence — and, as a result — of individual variation in the proteins encoded by our genes."
Weinshilboum said the study also was made possible by the large quantity of human DNA sequence information that is now publically available — with the proviso that those data must be carefully protected and must have their use reviewed and approved to avoid any possible violation of privacy.
As of July 11, 2022, more than 6.3 million people worldwide have died from COVID-19 since the start of the pandemic.
Acknowledgements
This study was funded by NIH grants U19 GM61388 (The Pharmacogenomics Research Network), R01 GM028157, R01 GM125633, R01 AA027486, K01 AA28050 and by the Mayo Clinic Centre for Individualised Medicine.


Clic here to read the story from its source.